OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 36 citing articles:

A novel golgi related genes based correlation prognostic index can better predict the prognosis of glioma and responses to immunotherapy
Beichuan Zhao, Ruoheng Xuan, Guitao Yang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2

Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1
Nathaniel W. Mabe, Min Huang, Guillermo Nicolás Dalton, et al.
Nature Cancer (2022) Vol. 3, Iss. 8, pp. 976-993
Open Access | Times Cited: 61

Biology of GD2 ganglioside: implications for cancer immunotherapy
Pierre Machy, Erwan Mortier, Stéphane Birklé
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 26

Cancer-Associated Glycosphingolipids as Tumor Markers and Targets for Cancer Immunotherapy
Sophie Groux‐Degroote, Philippe Delannoy
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 6145-6145
Open Access | Times Cited: 46

Bioactive sphingolipids as emerging targets for signal transduction in cancer development
Wentao Jia, Jiaying Yuan, Jinbo Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189176-189176
Closed Access | Times Cited: 7

The Challenging Melanoma Landscape: From Early Drug Discovery to Clinical Approval
Mariana Matias, Jacinta O. Pinho, Maria João Penetra, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 3088-3088
Open Access | Times Cited: 39

Glycosyltransferases in Cancer: Prognostic Biomarkers of Survival in Patient Cohorts and Impact on Malignancy in Experimental Models
Michela Pucci, Martina Duca, Nadia Malagolini, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2128-2128
Open Access | Times Cited: 28

Gangliosides and Neuroblastomas
Cara‐Lynne Schengrund
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5313-5313
Open Access | Times Cited: 32

Exploiting Gangliosides for the Therapy of Ewing’s Sarcoma and H3K27M-Mutant Diffuse Midline Glioma
Arthur Wingerter, Khalifa El Malki, Roger Sandhoff, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 520-520
Open Access | Times Cited: 26

Ganglioside GD2: a novel therapeutic target in triple‐negative breast cancer
Claire Shao, Vivek Anand, Michael Andreeff, et al.
Annals of the New York Academy of Sciences (2021) Vol. 1508, Iss. 1, pp. 35-53
Closed Access | Times Cited: 21

B4GALNT1 promotes progression and metastasis in lung adenocarcinoma through JNK/c-Jun/Slug pathway
Tian Jiang, Hao Wu, Miao Lin, et al.
Carcinogenesis (2020) Vol. 42, Iss. 4, pp. 621-630
Open Access | Times Cited: 21

A novel bioavailable curcumin-galactomannan complex modulates the genes responsible for the development of chronic diseases in mice: A RNA sequence analysis
Kishore Banik, Elina Khatoon, Mangala Hegde, et al.
Life Sciences (2021) Vol. 287, pp. 120074-120074
Closed Access | Times Cited: 19

Stromal Factors as a Target for Immunotherapy in Melanoma and Non-Melanoma Skin Cancers
Taku Fujimura
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 4044-4044
Open Access | Times Cited: 13

Multi-dimensional role of gangliosides in modulating cancer hallmarks and their prospects in targeted cancer therapy
Abhisek Sarkar, Sounak Banerjee, Kaushik Biswas
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7

Sphingolipids in embryonic development, cell cycle regulation, and stemness – Implications for polyploidy in tumors
Christina Voelkel‐Johnson
Seminars in Cancer Biology (2021) Vol. 81, pp. 206-219
Open Access | Times Cited: 14

B4GALNT1 promotes carcinogenesis by regulating epithelial–mesenchymal transition in hepatocellular carcinoma based on pan‐cancer analysis
Wenli Liu, Yutong Chen, Jinqiang Yang, et al.
The Journal of Gene Medicine (2023) Vol. 25, Iss. 11
Closed Access | Times Cited: 5

Sphingolipids: Less Enigmatic but Still Many Questions about the Role(s) of Ceramide in the Synthesis/Function of the Ganglioside Class of Glycosphingolipids
Cara‐Lynne Schengrund
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6312-6312
Open Access | Times Cited: 1

GD2-targeted theranostics of neuroblastoma with [64Cu]Cu/[177Lu]Lu-hu3F8
Lingling Zheng, Cuicui Li, Yang Xu, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Closed Access | Times Cited: 1

High-Risk HPV16 E6 Activates the cGMP/PKG Pathway Through Glycosyltransferase ST6GAL1 in Cervical Cancer Cells
Jun Wang, Gao Liu, Mei Liu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 10

Pan-Cancer Analysis of B4GALNT1 as a Potential Prognostic and Immunological Biomarker
Hang Yi, Yiwen Lin, Yutong Li, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-28
Open Access | Times Cited: 6

Identification of a Novel Glycosyltransferase Prognostic Signature in Hepatocellular Carcinoma Based on LASSO Algorithm
Zhiyang Zhou, Tao Wang, Yao Du, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 5

Neuroblastoma GD2 Expression and Computational Analysis of Aptamer-Based Bioaffinity Targeting
Godfred Sabbih, Michael K. Danquah
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 9101-9101
Open Access | Times Cited: 7

Machine Learning-Based Identification of B4GALNT1 as a Key Player in Hepatocellular Carcinoma: A Comprehensive Bioinformatics and Structural Analysis
Rohit Kumar Verma, Kiran Bharat Lokhande, Prashant Kumar Srivastava, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Elucidating B4GALNT1 as Potential Biomarker in Hepatocellular Carcinoma using Machine Learning Models and Mutational Dynamics Explored through MD Simulation
Rohit Kumar Verma, Kiran Bharat Lokhande, Prashant Kumar Srivastava, et al.
Informatics in Medicine Unlocked (2024) Vol. 48, pp. 101514-101514
Open Access

Page 1 - Next Page

Scroll to top